Collaboration integrates AJICAP™ technology with global manufacturing capabilities to streamline antibody-drug conjugate pipelines
The aim is to bolster healthcare delivery in a region increasingly burdened by chronic disease
New purpose-built AI model targets faster R&D cycles and deeper scientific insights across life sciences
The collaboration combines Alveus’ expertise in metabolic biology and therapeutic strategy with Aurigene’s integrated discovery capabilities
The CE Mark builds on the company’s ISO 13485 certification, further strengthening confidence in the platform's safety, quality and performance
The event marks a significant push into South Korea’s rapidly expanding bio-health ecosystem
Dr Desai argued that the sector is undergoing a structural acceleration in how quickly science turns into treatments
The companies plan to advance multiple solid tumor targets from Regeneron’s antibody portfolio
The investigational therapy, ifinatamab deruxtecan, is a potential first-in-class B7-H3 directed DXd antibody drug conjugate discovered by Daiichi Sankyo and jointly developed with Merck
Strategic expansion strengthens CDMO’s support for biotech and pharma innovators across the Asia-Pacific region
Subscribe To Our Newsletter & Stay Updated
